肝硬化腹水

血清C反应蛋白测定在肝硬化腹水合并感染早期的应用

Study on the application of CRP in the early stage of ascites due to cirrhosis complicated with infection

肝硬化腹水的中药治疗

Treatment of Ascites due to Cirrhosis with Traditional Chinese Drug

肝癌与肝硬化腹水微量元素Cu、Zn测定的临床诊断价值

The Clinical Value of Determination Copper and Zinc in Ascites of Hepatoma and Hepatocirrhosis

结论：C反应蛋白测定可作为诊断肝硬化腹水并发腹水早期感染的一个较敏感指标。

Conclusion CRP is a sensitive mark to diagnose infection in the early stage of the patient with ascites due to cirrhosis complicated with infection .

ET在急性肝炎、慢性肝炎、肝硬化腹水发病中起着重要作用。

ET palyed an important role in the development of acute , chronic , cirrhosis with ascites .

对21例肝硬化腹水病人作肺功能测定，并与50名正常人进行对照。肝硬化组VC为93.67±12.57%，对照组为102.47±15.22%，P<0.05；

Pulmonary function tests were performed in 21 cirrhotic patients with ascites and 50 normal persons as controls .

肝硬化腹水组血浆ET水平均显著降低；

The plasm level of ET in cirrhosis with ascites group ( including with and without SBP ) was decreased significantly ;

方法：对162例肝硬化腹水合并感染患者在治疗前和感染控制后应用C反应蛋白乳胶玻片凝集试验检测，并进行自身对照；

Methods One hundred and sixty-two cases of ascites due to cirrhosis complicated with infection were detected CRP with lactoprene coagulant glass test method and compared the results before and after treatment .

目的：探讨实验性肝硬化腹水SD大鼠去腹水过程中小茴香的补钾、抗纤维化作用及其机制。

Objective : To study the effect of potassium supplement and anti-fibrosis of foeniculum vulgare mill on liver cirrhosis ascites in SD rats .

双氢克尿塞（C组）和中药小茴香（D组）对肝硬化腹水大鼠总排尿量有明显的促进作用，与B组比较，差异有统计学意义（P<0.05）。

The total volume of urine in group C and group D was more than group B. Compared with group B , both C and D groups had significant difference ( P < 0.05 ) .

中药小茴香具有降低肝硬化腹水大鼠ALD、NOS水平的作用。

Chinese herb Foeniculum Vulgare Mill could decrease the levels of ALD and NOS of liver fibrosis ascites rats .

方法对336例住院肝硬化腹水并发SBP临床资料进行前瞻性调查。

Methods : A prospective study was performed in 336 cases of SBP in patients with hepatic cirrhosis .

目的：探讨内皮素－1（ET－1）、一氧化氮（NO）、强啡肽A（DynA）在肝硬化腹水形成中的作用。

Objective : To study the role of ET-1 , NO and DynA on pathogenesis of ascites in liver cirrhosis .

新药（如V2受拮抗剂和血管收缩剂等）对肝硬化腹水的治疗可能带来希望。

New medicines such as vasoconstrictors and V2-receptors of vasopressin maybe beneficial in patients with ascites in liver cirrhosis .

结果肝硬化腹水组的阻力指数（RI）、肾血流量（Q）与肝硬化无腹水组、正常对照组比较，具有显著性的差异（P<0.01）；

Results The resistive index and renal blood volume were significant difference in cirrhosis with ascites than in cirrhosis without ascites and healthy controls ( P < 0.01 ) .

评价静脉注射人血白蛋白（HSA）对肝硬化腹水患者血浆ATⅡ、VAP、CGRP、ET、肾功能的影响及其作用机制。

Assess the effect of intravenous human serum albumin ( HSA ) on serum AT ⅱ, VAP , CGRP , ET levels and renal function .

但肝硬化腹水组肾动脉阻力指数（RI）和搏动指数（PI）均显著高于其余两组（P

But resistive index ( RI ) and pulsatile index ( PI ) were markedly higher in cirrhotic patients with ascites than that in cirrhotic patients without ascites and that in the control group ( P

结果：1肝硬化腹水患者LBP、CGRP水平显著高于无腹水者和正常对照组（P＜0.05）；

Results : 1 The levels of LBP and CGRP in liver cirrhosis patients with ascite were higher than patients without ascite and health control group significantly ( P < 0.05 ) .

目的：探讨肝硬化腹水合并自发性细菌性腹膜炎（SBP）菌株种类、临床特点和预后。

Objective : Bacterium type , clinic character and prognosis of hepatocirrhosis ascites with spontaneous bacillary peritonitis ( SBP ) were discussed in this study .

结论TIPSS手术可明显改善肝硬化腹水患者肾血流灌注和肾功能，并可成为治疗肝肾综合征（HRS）的有效手段，而对于肝硬化无腹水患者的肾血流动力学及肾功能则无明显影响。

Conclusions The renal hemodynamics in patients with ascites was markedly improved after TIPSS , but there were no changes in patients without ascites .

结果（1）肝硬化腹水患者的血清CHE、白蛋白均明显低于对照组。

Results 1 , the concentration of the serum CHE and albumin in patients suffering from hepatocirrhosis with ascites are much lower than those of the controls .

方法：对108例次腹水细菌培养阳性肝硬化腹水合并SBP患者的临床资料以及腹水细菌培养和药物敏感试验结果进行回顾性分析。

Methods : The clinical data , the results of bacterial culture and drug sensitivity tests of 108 ascitic specimens from cirrhotic patients with SBP were analyzed retrospectively .

结论：Child-Pugh分级、血清胆红素、外周血中性粒细胞百分比及腹水蛋白浓度可能是肝硬化腹水患者并发SBP的4个独立影响因素。

Conclusion : The child-pugh grade score , serum bilirubin level , neutrophil percentage and ascitic fluid albumin were independently associated with risk factors of SBP .

健脾益肝方对肝硬化腹水NO及ET-1调节的相关性研究

Relative Studies on the Modulation of NO and ET-1 in Cirrhosis with Ascites Treated with Formula of Invigorating Spleen and Tonifying Liver ; The pathogenesis and renal circulation regulation of hepatorenal syndrome

死亡组4项指标与对照组相比差异在10倍左右，肝破裂、肝硬化腹水组KPTT高于对照组10倍以上，FIB、AT低于对照组一半以下。

The difference in death group was up to 10 times ; KPTT in Hepatorrhexis and Cirrhosis group was higher than 10 times ;

结果显示：肝硬化腹水大鼠血浆和肾组织匀浆中cGMP水平显著高于假手术组，24h尿钠排泄量则显著低于假手术组。

The results showed that the concentration of cGMP in plasma and homogenates of renal tissue of CIR rats was significantly lower and urinary sodium excretion significantly lower than that in SO rats .

目的：观察中药脐敷结合中药灌肠对难治性肝硬化腹水诱发氮质血症的临床疗效，及对一氧化氮（NO）、内皮素（ET）、内毒素含量的影响。

Objective : To observe the clinical therapeutic effect of the Chinese medicine paved on the umbilicus and enema in the treatment of refractory cirrhosis ascites with azotemia . To observe the content of NO , ET and endotoxin in blood serum .

结论动态观察血清CHE水平，对判断肝硬化腹水患者临床痊愈后短期内腹水是否复发具有重要价值。

Conclusion It is of significance to observe the trends of the concentration of the serum CHE for the patients suffering from hepatocirrhosis with ascites after the clinical healing when judging whether the ascites recur or not .

以自拟健脾柔肝消水方治疗肝硬化腹水108例，3M为1疗程，1～2个疗程后，总有效率907%

Self made " Spleen Nourishing , Liver Softening and Water Removing Decoction " was used to treat ascites due to cirrhosis for 1 ~ 2 courses , 3 months in one course . Results showed the total effective rate was 90.7 % .

结论：血清高胆红素、腹水低蛋白和腹水PMN是肝硬化腹水并发SBP的危险因素，可以作为早期诊断和治疗SBP的实验指标。

Conclusion : High serum bilirubin , low albumin of ascites and PMN of ascites were dangerous factors of hepatocirrhosis ascites with spontaneous bacillary peritonitis , and it may be a experiment index in forepart diagnosing and treating hepatocirrhosis ascites with spontaneous bacillary peritonitis .